OracleORCLBUY ON WEAKNESSMar 20, 2024Stock price when the opinion was issued
As of Sep 15, 2026. Market Open.
They just reported: 30% topline revenue growth, free cash flow a lot better than expected, though still negative because they're investing in the business. They did not announce new capex plans. Their current default swaps are starting to make a difference, from 215 bps a few weeks ago, and now at 181 bps. Lots to like, but shares are down because interest rates are up in recent days. You can buy on weakness now. Their capex spend will remain an overhang, though.
Hyperscaler. Ran into issues with a series of announcements that amounted to running up a bill of $80B. So then they had to get financing and raise $20B in stock issuance. Reports next week. Price target of $258, and you won't find a much longer runway. Yield is 1.35%.
(Analysts’ price target is $245.49)Generated $32B of operating cashflow last year. FCF is negative because they spent roughly $56B building AI data centres. Investors are willing to tolerate that spending because of extraordinary demand. Wouldn't expect a FCF reversal while the buildout continues, but those new data centres will produce revenue.
Rebound potential. Wait and see, earnings next week. She has only a 1/2 position now, and will see what the earnings report says.
Tough, because both are very fully priced. On any pullback of MSFT to around $410, you could pick it up.
ORCL is already through his price target. But he likes it so much, he's been selling calls against it. His 12-month price target was $126, and here it is almost $127. Running on all cylinders on both cloud and software.
If you own either, write calls. But if they roll over 5%, pick some up.